Wei Zhang

机构：Zhejiang Chinese Medical University, Guangdong Pharmaceutical University

发表论文 9 篇 · 总被引 86 次 · h-index 4

代表论文

• Gegen Qinlian decoction ameliorates TNBS-induced ulcerative colitis by regulating Th2/Th1 and Tregs/Th17 cells balance, inhibiting NLRP3 inflammasome activation and reshaping gut microbiota (2024 · Journal of Ethnopharmacology · 被引 56)
• A CXCR4-targeted immunomodulatory nanomedicine for photodynamic amplified immune checkpoint blockade therapy against breast cancer (2025 · Acta Biomaterialia · 被引 10)
• CILP2: A prognostic biomarker associated with immune infiltration in colorectal cancer (2023 · Heliyon · 被引 7)
• Huanglian Ejiao Decoction Alleviates Ulcerative Colitis in Mice Through Regulating the Gut Microbiota and Inhibiting the Ratio of Th1 and Th2 Cells (2025 · Drug Design Development and Therapy · 被引 4)
• Correlation and diagnostic significance of CD4 T cell subsets and NLRP3 inflammasome in ulcerative colitis: the role of the NLRP3/T-bet/GATA3 axis (2025 · BMC Gastroenterology · 被引 2)
• Progress in diagnosis and treatment of gastric cancer from the “Five-For-One” holistic treatment model (2023 · Asian Journal of Surgery · 被引 1)